XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2018
Accounting Policies [Abstract]  
Summary of Marketable Security

Below is a summary of each type of marketable security held by the Company at December 31, 2018:

 

Type of Marketable Secutiry   Estimated Market Value  
U.S. Treasury Bills   $ 149,954  
U.S. Treasury Notes   $ 100,434  
Total at December 31, 2018   $ 250,388  

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2018.

 

    Carrying     Fair Value Measurement Using  
    Value     Level 1     Level 2     Level 3     Total  
                               
Marketable securities     250,388       250,388                   250,388  
Derivative warrants liabilities   $ (676,079 )   $     $     $ (676,079 )   $ (676,079 )

 

The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2017.

  

    Carrying     Fair Value Measurement Using  
    Value     Level 1     Level 2     Level 3     Total  
                               
Marketable securities     1,285,753       1,285,753                   1,285,753  
Derivative warrants liabilities   $ (425,838 )   $     $     $ (425,838 )   $ (425,838 )

Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended December 31, 2018 and 2017:

 

   

Fair Value Measurement

Using Level 3

 
    Inputs Total  
Balance, December 31, 2016   $ 516,870  
Change in fair value of derivative warrants liabilities     (91,032 )
Balance, December 31, 2017     425,838  
Change in fair value of derivative warrants liabilities     250,241  
Balance, December 31, 2018   $ 676,079  

Schedule of Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques

    December 31, 2017     December 31, 2018  
Exercise price     1.25       1.25  
Risk free interest rate     1.98 %     2.46 %
Dividend yield     0.00 %     0.00 %
Expected volatility     144 %     152 %
Contractual term     3.15 Years       2.15 Years  

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

    Potentially Outstanding 
Dilutive Common Shares
 
    For the Year Ended 
December 31, 2018
    For the Year Ended 
December 31, 2017
 
             
Conversion Feature Shares                
                 
Common shares issuable under the conversion feature of preferred shares     872,766       872,766  
                 
Stock Option     3,846,299       3,566,299  
                 
Warrant     3,826,658       3,826,658  
                 
Total potentially outstanding dilutive common shares     8,545,723       8,265,723